Dr. Osborn is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
9100 Babcock Blvd
Pittsburgh, PA 15237Phone+1 413-367-6454Fax+1 412-367-6913
Education & Training
UPMC Medical EducationFellowship, Hematology and Medical Oncology, 1993 - 1996- UPMC Medical EducationResidency, Internal Medicine, 1990 - 1993
Ohio State University College of MedicineClass of 1990
Certifications & Licensure
PA State Medical License 1993 - 2024- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 70 citationsPhase II trial of short-course CHOP-R followed by 90Y-ibritumomab tiuxetan and extended rituximab in previously untreated follicular lymphoma.Samuel A. Jacobs, Steven H. Swerdlow, Jeffrey A. Kant, Kenneth A. Foon, Rachel C. Jankowitz
Clinical Cancer Research. 2008-11-01 - 125 citationsPhase II trial of oral 1,25-dihydroxyvitamin D (calcitriol) in hormone refractory prostate cancer.Jennifer L. Osborn, Gary G. Schwartz, David C. Smith, Robert R. Bahnson, Roger Day
Urologic Oncology. 1995-09-01 - 22 citationsMegestrol acetate in the treatment of hormone refractory prostate cancer.Jennifer L. Osborn, David C. Smith, Donald L. Trump
American Journal of Clinical Oncology. 1997-06-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
